Hyperfine's Swoop system featured in neurosurgery and stroke journals
Get Alerts HYPR Hot Sheet
Join SI Premium – FREE
Hyperfine, Inc. (Nasdaq: HYPR) announced the release of multiple peer-reviewed publications in the Journal of Neurosurgery and Stroke supporting clinical use of its Swoop portable MRI system in neurosurgical and stroke care settings, according to a company press release.
The July 2026 issue of the Journal of Neurosurgery featured cases from an ambulatory neurosurgery center where the Swoop system was used to image patients immediately following endovascular neurosurgical procedures. The imaging helped confirm the absence of findings such as acute ischemic or intracranial hemorrhage, enabling same-day patient discharge.
Stroke published a collection of articles examining low-field MRI across stroke care settings, including pre-hospital stroke care, acute stroke, neurocritical care, and cerebral small vessel disease. The articles review existing data, present new evidence, and offer guidance on implementation.
"The cases published in the Journal of Neurosurgery provide early evidence that immediate access to on-site imaging can inform post-procedural decision-making and help avoid unnecessary delays or hospital admissions," said Edmond Knopp, MD, Hyperfine Chief Medical Officer.
Hyperfine states the Swoop system is now supported by more than 180 peer-reviewed publications and editorials and over 280 scientific presentations across multiple care settings. The system holds FDA clearance for brain imaging of patients of all ages.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loop Capital Starts Klarna (KLAR) at Hold
- Medicure presents Phase 3 PNPO study data at European Epilepsy Congress
- Allegion names Serge Zappone to lead international unit
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Definitive Agreement, Maynard Um, Mark Zuckerberg, FDA, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share